Three New Directors Join Digirad’s Board

Digirad Corp., which offers solid-state medical imaging products and services, recently reported a net loss of $1.2 million on revenue of $13 million during the first quarter of the year. That compares with a net loss of $387,000 on revenue of $14.1 million in the same quarter one year ago.

Digirad also recently announced that its stockholders have selected three new independent directors: Jeffrey E. Eberwein, Charles M. Gillman and James B. Hawkins. Leaving their seats on the board were Steven C. Mendell and Kenneth E. Olson.

Company stock trades on the Nasdaq as DRAD. Digirad operates under the direction of Chairman R. King Nelson and CEO Todd Clyde. The company is based in Poway.